Learn how to analyze recent clinical data of current and emerging targeted therapies and potential biomarkers for severe asthma, as well as how to select personalized treatment approaches for severe asthma best suited to various phenotypes and endotypes.  This multidisciplinary expert roundtable discussion, moderated by Flavia Hoyte, MD, with Anthony Gerber, MD, PhD, and Michael Wechsler, MD, MMSc, will provide critical perspective and insight into the multidisciplinary approach to disease treatment and management and realistic tools to put into practice in a busy setting.  This module incorporates video-recorded patient cases to apply learning, increase interactivity, and provide an innovative format.

This activity is accredited for .75 AMA PRA Category 1 Credits™.  It will take approximately 45 minutes to complete the module including the pre/post-test and evaluation.  You will receive rationale for the post-test questions as a learning tool.

 

Register for this Course
National Jewish Health
1400 Jackson Street
Denver, CO 80206
© 2017 National Jewish Health


Grant Statement
This educational activity is supported by educational grants from AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, and Sanofi Genzyme and Regeneron Pharmaceuticals.